The company has consistently featured among the top global employers for eight consecutive years, since its debut on the list in 2012. According to the Top Employers Survey of approximately 7,600 respondents from across the world this year, Biocon’s ranking was based on three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’.
This year, the survey took place from March 3 through May 3, when companies globally were grappling with quarantines and lockdowns in response to COVID-19. In these extraordinary circumstances, Biocon reinforced its reputation of resilience and reliability by continuing to manufacture and supply life-saving therapies worldwide while prioritizing the health and safety of its employees through comprehensive safety measures at its facilities.
Biocon Executive Chairperson Kiran Mazumdar-Shaw said, “We are delighted to be ranked among the Top Five Global Biotech Employers by Science Magazine. The ranking is a recognition of the passion that our employees bring to the job, which allowed us to run essential and critical manufacturing, quality and supply operations with reduced staffing despite the severe disruptions caused by the COVID-19 outbreak, thus minimizing the impact on patients and partners. Their commitment also enabled us to rapidly develop novel therapeutics for the deadly coronavirus and serve humanity by fighting COVID-19.”
“We will continue to build on Biocon’s employee-friendly culture that promotes ideation, experimentation and collaboration as we aspire to create future leaders who will revolutionize healthcare through innovative products and services,” she added. The Top 5 global players in this year’s list are Regeneron, Alnylam, Incyte, Syngenta and Biocon. 2 Biocon was ahead of leading global pharma companies like Novo Nordisk, Roche, Eli Lilly, Abbott, Novartis, Pfizer etc. in the 2020 rankings.
For the companies that emerged in the top 20, remarks from respondents reflected their pride and gratitude in the fact that the organizations they represented had continuously invested in their well-being while still putting science and patients first. When employees see meaningful action by their employers that is designed to empower and support them in every way possible, they respond in kind: They produce their best work. And in the arena of pharma and biotech, that easily translates into better patient outcomes, The American Association for the Advancement of Science (AAAS) said.
DNA of Top Employers: The winning formulation that puts companies on the Top Employers list? Chief among the ingredients is an articulated mission of supporting scientists and science. Almost all of the top employers indicated that they are science- and patient-centered, AAAS added.
Biocon Ltd ended at Rs403.60 per piece down by Rs0.3 or 0.07% from its previous closing of Rs403.90 on the BSE.